ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Figure 1Loading Img

Targeted m6A Reader Proteins To Study Epitranscriptomic Regulation of Single RNAs

Cite this: J. Am. Chem. Soc. 2018, 140, 38, 11974–11981
Publication Date (Web):September 5, 2018
Copyright © 2018 American Chemical Society

    Article Views





    Other access options
    Supporting Info (1)»


    Abstract Image

    Post-transcriptional gene expression regulation of RNA has emerged as a key factor that controls mammalian protein production. RNA trafficking, translation efficiency, and stability are all controlled at the transcript level. For example, in addition to the commonly known processing steps of capping, splicing, and polyadenylation, RNA can be chemically modified. In eukaryotes, N6-methyladenosine (m6A) is the most prevalent mRNA modification. While the writers, erasers, and readers for m6A are rapidly being uncovered and studied at the whole-cell level, their competitive interplay to regulate methylated RNA transcripts has yet to be elucidated. To address this limitation, we report the development of programmable dPspCas13b-m6A reader proteins to investigate the regulatory effects of specific readers on single transcripts in live cells. We fused the two most well-characterized m6A reader proteins, YTHDF1 and YTHDF2, to a catalytically inactive PspCas13b protein, which can target the reader to a specific RNA of interest using guide RNA (gRNA) complementarity. We then demonstrate that the fused reader proteins each retain their reported functional role on a reporter construct: YTHDF2 induces degradation and YTHDF1 enhances translation. Finally, we show that the system can target endogenous mRNA transcripts within cells, using YTHDF2 as an exemplar, where we found tethering with YTHDF2 leads to decay of the target transcript. The development of dCas13b-based tools to study the regulation of endogenous RNAs will dramatically enhance our understanding of how RNA regulation occurs at the single RNA level. Additionally, our new tools, which permit transcript-specific mediated decay or enhanced protein production, will find utility in synthetic biology applications aimed at controlling genetic information flow at the RNA level.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    Jump To

    The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/jacs.8b05012.

    • Supporting tables and figures (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:

    Cited By

    This article is cited by 83 publications.

    1. Ying Xu, Na Tian, Huaxia Shi, Chenwei Zhou, Yufan Wang, Fu-Sen Liang. A Split CRISPR/Cas13b System for Conditional RNA Regulation and Editing. Journal of the American Chemical Society 2023, 145 (9) , 5561-5569.
    2. Simone Rauch, Krysten A. Jones, Bryan C. Dickinson. Small Molecule-Inducible RNA-Targeting Systems for Temporal Control of RNA Regulation. ACS Central Science 2020, 6 (11) , 1987-1996.
    3. Kyung W. Seo, Ralph E. Kleiner. YTHDF2 Recognition of N1-Methyladenosine (m1A)-Modified RNA Is Associated with Transcript Destabilization. ACS Chemical Biology 2020, 15 (1) , 132-139.
    4. Jing Hu, Shizhi Wang, Xiuting Li. A comprehensive review of m 6 A research in cervical cancer. Epigenomics 2024, 19
    5. Monika Witzenberger, Schraga Schwartz. Directing RNA-modifying machineries towards endogenous RNAs: opportunities and challenges. Trends in Genetics 2024, 40 (4) , 313-325.
    6. Riley W. Sinnott, Yang Cao, Bryan C. Dickinson. Engineered RNA‐binding Proteins: Studying and Controlling RNA Regulation. Israel Journal of Chemistry 2024, 14
    7. Wenting Luo, Youjia Zhou, Jiayang Wang, Keqin Wang, Qing Lin, Yuqiu Li, Yujie Xie, Miao Li, Jie Wang, Lixia Xiong. YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network. International Journal of Molecular Sciences 2024, 25 (3) , 1879.
    8. Fei Han. N-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential. Heliyon 2024, 10 (3) , e25192.
    9. Jonas Cerneckis, Guo-Li Ming, Hongjun Song, Chuan He, Yanhong Shi. The rise of epitranscriptomics: recent developments and future directions. Trends in Pharmacological Sciences 2024, 45 (1) , 24-38.
    10. Yang Cao, Huachun Liu, Shannon S. Lu, Krysten A. Jones, Anitha P. Govind, Okunola Jeyifous, Christine Q. Simmons, Negar Tabatabaei, William N. Green, Jimmy. L. Holder, Soroush Tahmasebi, Alfred L. George, Bryan C. Dickinson. RNA-based translation activators for targeted gene upregulation. Nature Communications 2023, 14 (1)
    11. Yuanli Gao, Lei Wang, Baojun Wang. Customizing cellular signal processing by synthetic multi-level regulatory circuits. Nature Communications 2023, 14 (1)
    12. Beibei Wang, Hui Yang. Progress of CRISPR ‐based programmable RNA manipulation and detection. WIREs RNA 2023, 14 (6)
    13. Yongjie Cai, Ruiqing Yu, Zhanqi Zhang, Di Li, Baicheng Yi, Zhihui Feng, Qiong Xu. Mettl3/Ythdf2 regulate macrophage inflammation and ROS generation by controlling Pyk2 mRNA stability. Immunology Letters 2023, 30
    14. Sachithrani U. Madugalle, Wei-Siang Liau, Qiongyi Zhao, Xiang Li, Hao Gong, Paul R. Marshall, Ambika Periyakaruppiah, Esmi L. Zajaczkowski, Laura J. Leighton, Haobin Ren, Mason R. B. Musgrove, Joshua W. A. Davies, Gwangmin Kim, Simone Rauch, Chuan He, Bryan C. Dickinson, Barbora Fulopova, Lee N. Fletcher, Stephen R. Williams, Robert C. Spitale, Timothy W. Bredy. Synapse-Enriched m 6 A-Modified Malat1 Interacts with the Novel m 6 A Reader, DPYSL2, and Is Required for Fear-Extinction Memory. The Journal of Neuroscience 2023, 43 (43) , 7084-7100.
    15. Ying Xu, Yufan Wang, Fu‐Sen Liang. Site‐Specific m 6 A Erasing via Conditionally Stabilized CRISPR‐Cas13b Editor. Angewandte Chemie 2023, 135 (43)
    16. Ying Xu, Yufan Wang, Fu‐Sen Liang. Site‐Specific m 6 A Erasing via Conditionally Stabilized CRISPR‐Cas13b Editor. Angewandte Chemie International Edition 2023, 62 (43)
    17. Yong Lin, Guangying Luo, Qi Liu, Rusen Yang, Peter Sol Reinach, Dongsheng Yan. METTL3-Mediated RNA m 6 A Modification Regulates the Angiogenic Behaviors of Retinal Endothelial Cells by Methylating MMP2 and TIE2. Investigative Opthalmology & Visual Science 2023, 64 (13) , 18.
    18. Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge. Changes in m6A in Steatotic Liver Disease. Genes 2023, 14 (8) , 1653.
    19. Vilbert Sikorski, Simona Selberg, Maciej Lalowski, Mati Karelson, Esko Kankuri. The structure and function of YTHDF epitranscriptomic m6A readers. Trends in Pharmacological Sciences 2023, 44 (6) , 335-353.
    20. Lin Chen, Yang Gao, Simiao Xu, Jinxiong Yuan, Min Wang, Tianyu Li, Jun Gong. N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms. Frontiers in Immunology 2023, 14
    21. Roser Montagud-Martínez, Rosa Márquez-Costa, Guillermo Rodrigo. Programmable regulation of translation by harnessing the CRISPR-Cas13 system. Chemical Communications 2023, 59 (18) , 2616-2619.
    22. Yueqi Ni, Hong Zhang, Liang Chu, Yin Zhao. m6A Modification—Association with Oxidative Stress and Implications on Eye Diseases. Antioxidants 2023, 12 (2) , 510.
    23. Fu-Sen Liang, Ying Xu. RNA Epigenetics and Epitranscriptomics: The Emerging Gene Regulatory Landscape Through RNA Modifications. 2023, 580-591.
    24. Shimin Wu, Pingfang Tian, Tianwei Tan. CRISPR-Cas13 technology portfolio and alliance with other genetic tools. Biotechnology Advances 2022, 61 , 108047.
    25. Jorik F Bot, John van der Oost, Niels Geijsen. The double life of CRISPR–Cas13. Current Opinion in Biotechnology 2022, 78 , 102789.
    26. Jingyu Liao, Yi Wei, Junnan Liang, Jingyuan Wen, Xiaoping Chen, Bixiang Zhang, Liang Chu. Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins. Cell Death Discovery 2022, 8 (1)
    27. Huaxia Shi, Ying Xu, Na Tian, Ming Yang, Fu-Sen Liang. Inducible and reversible RNA N6-methyladenosine editing. Nature Communications 2022, 13 (1)
    28. Jianzhong Hu, Jing Cai, Tao Xu, Hunseung Kang. Epitranscriptomic mRNA modifications governing plant stress responses: underlying mechanism and potential application. Plant Biotechnology Journal 2022, 20 (12) , 2245-2257.
    29. E. V. Kropocheva, L. A. Lisitskaya, A. A. Agapov, A. A. Musabirov, A. V. Kulbachinskiy, D. M. Esyunina. Prokaryotic Argonaute Proteins as a Tool for Biotechnology. Molecular Biology 2022, 56 (6) , 854-873.
    30. Andre L.M. Reis, Jillian M. Hammond, Igor Stevanovski, Jonathon C. Arnold, Iain S. McGregor, Ira W. Deveson, Anand Gururajan. Sex-specific transcriptomic and epitranscriptomic signatures of PTSD-like fear acquisition. iScience 2022, 25 (9) , 104861.
    31. Aierpati Maimaiti, Abudireheman Tuersunniyazi, Xianghong Meng, Yinan Pei, Wenyu Ji, Zhaohai Feng, Lei Jiang, Zengliang Wang, Maimaitijiang Kasimu, Yongxin Wang, Xin Shi. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Frontiers in Genetics 2022, 13
    32. Danyu Chen, Henley Cheung, Harry Cheuk-Hay Lau, Jun Yu, Chi Chun Wong. N6-Methyladenosine RNA-Binding Protein YTHDF1 in Gastrointestinal Cancers: Function, Molecular Mechanism and Clinical Implication. Cancers 2022, 14 (14) , 3489.
    33. Martyna Kordyś, Raneet Sen, Zbigniew Warkocki. Applications of the versatile CRISPR‐Cas13 RNA targeting system. WIREs RNA 2022, 13 (3)
    34. Bernard Nsengimana, Faiz Ali Khan, Ebenezeri Erasto Ngowi, Xuefeng Zhou, Yu Jin, Yuting Jia, Wenqiang Wei, Shaoping Ji. Processing body (P-body) and its mediators in cancer. Molecular and Cellular Biochemistry 2022, 477 (4) , 1217-1238.
    35. Qiwei Yang, Ayman Al-Hendy. The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer. Cells 2022, 11 (7) , 1149.
    36. Dhivya Selvaraj, Rajni Dawar, Pradeep Kumar Sivakumar, Anita Devi. Clustered regularly interspaced short palindromic repeats, a glimpse – impacts in molecular biology, trends and highlights. Hormone Molecular Biology and Clinical Investigation 2022, 43 (1) , 105-112.
    37. Ruigong Zhu, Xian Ji, Xuan Wu, Jiajing Chen, Xuesong Li, Hong Jiang, Haiping Fu, Hui Wang, Zhe Lin, Xin Tang, Shixiu Sun, Qingguo Li, Bingjian Wang, Hongshan Chen. Melatonin antagonizes ovarian aging via YTHDF2-MAPK-NF-κB pathway. Genes & Diseases 2022, 9 (2) , 494-509.
    38. Shuying Feng, Zilong Wang, Aifang Li, Xin Xie, Junjie Liu, Shuxuan Li, Yalan Li, Baiyan Wang, Lina Hu, Lianhe Yang, Tao Guo. Strategies for High-Efficiency Mutation Using the CRISPR/Cas System. Frontiers in Cell and Developmental Biology 2022, 9
    39. Yingfeng Su, Yasen Maimaitiyiming, Lingfang Wang, Xiaodong Cheng, Chih-Hung Hsu. Modulation of Phase Separation by RNA: A Glimpse on N6-Methyladenosine Modification. Frontiers in Cell and Developmental Biology 2021, 9
    40. Ralf P. Brandes, Anne Dueck, Stefan Engelhardt, Manuel Kaulich, Christian Kupatt, Maria Teresa De Angelis, Matthias S. Leisegang, Ferdinand le Noble, Alessandra Moretti, Oliver J. Müller, Boris V. Skryabin, Thomas Thum, Wolfgang Wurst. DGK and DZHK position paper on genome editing: basic science applications and future perspective. Basic Research in Cardiology 2021, 116 (1)
    41. Zuyao Chen, Xiaolin Zhong, Min Xia, Jing Zhong. The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases. Molecular Therapy - Nucleic Acids 2021, 26 , 1270-1279.
    42. Xiaojun Ren, Ruijie Deng, Kaixiang Zhang, Yupeng Sun, Yue Li, Jinghong Li. Single‐Cell Imaging of m 6 A Modified RNA Using m 6 A‐Specific In Situ Hybridization Mediated Proximity Ligation Assay (m 6 AISH‐PLA). Angewandte Chemie 2021, 133 (42) , 22828-22833.
    43. Xiaojun Ren, Ruijie Deng, Kaixiang Zhang, Yupeng Sun, Yue Li, Jinghong Li. Single‐Cell Imaging of m 6 A Modified RNA Using m 6 A‐Specific In Situ Hybridization Mediated Proximity Ligation Assay (m 6 AISH‐PLA). Angewandte Chemie International Edition 2021, 60 (42) , 22646-22651.
    44. Bing Han, Saisai Wei, Fengying Li, Jun Zhang, Zhongxiang Li, Xiangwei Gao. Decoding m6A mRNA methylation by reader proteins in cancer. Cancer Letters 2021, 518 , 256-265.
    45. Huachun Liu, Simone Rauch, Bryan C. Dickinson. Programmable technologies to manipulate gene expression at the RNA level. Current Opinion in Chemical Biology 2021, 64 , 27-37.
    46. Michael C. Owens, Celia Zhang, Kathy Fange Liu. Recent technical advances in the study of nucleic acid modifications. Molecular Cell 2021, 81 (20) , 4116-4136.
    47. Luchen Ai, Yue Wang, Yunlei Zhou, Huanshun Yin. Photoelectrochemical biosensor for N6-methyladenosine detection based on enhanced photoactivity of TiO2-X and MoS2 nanocomposite. Journal of Electroanalytical Chemistry 2021, 895 , 115444.
    48. Tian Tang, Yingli Han, Yuran Wang, He Huang, Pengxu Qian. Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications. Frontiers in Cell and Developmental Biology 2021, 9
    49. Yi Liu, Guanghao Liang, Hongjiao Xu, Wenxin Dong, Ze Dong, Zhiwei Qiu, Zihao Zhang, Fangle Li, Yue Huang, Yilin Li, Jun Wu, Shenyi Yin, Yawei Zhang, Peijin Guo, Jun Liu, Jianzhong Jeff Xi, Peng Jiang, Dali Han, Cai-Guang Yang, Meng Michelle Xu. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metabolism 2021, 33 (6) , 1221-1233.e11.
    50. Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri, Pilar Blancafort. Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing. Molecular Therapy - Methods & Clinical Development 2021, 21 , 592-606.
    51. Godwin Sokpor, Yuanbin Xie, Huu P. Nguyen, Tran Tuoc. Emerging Role of m6 A Methylome in Brain Development: Implications for Neurological Disorders and Potential Treatment. Frontiers in Cell and Developmental Biology 2021, 9
    52. Min Li, Xuan Zha, Shengjun Wang. The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021, 1875 (2) , 188522.
    53. Linjie Yin, Xiao Zhu, Petr Novák, Le Zhou, Ling Gao, Min Yang, GuoJun Zhao, Kai Yin. The epitranscriptome of long noncoding RNAs in metabolic diseases. Clinica Chimica Acta 2021, 515 , 80-89.
    54. Taizo TAMURA, Takahiro NAKAMURA. The Development of DNA/RNA-Editing Technology Using PPR Protein, a Plant Specific Nucleotide Binding Module: Establishment of a New DNA/RNA Engineering Platform. KAGAKU TO SEIBUTSU 2021, 59 (3) , 113-121.
    55. P Cody He, Chuan He. m 6 A RNA methylation: from mechanisms to therapeutic potential. The EMBO Journal 2021, 40 (3)
    56. Kyung W. Seo, Ralph E. Kleiner. Mechanisms of epitranscriptomic gene regulation. Biopolymers 2021, 112 (1)
    57. Veerendra Sharma, Wenguang Zheng, Jun Huang, David E. Cook. CRISPR-Cas RNA Targeting Using Transient Cas13a Expression in Nicotiana benthamiana. 2021, 1-18.
    58. Vivien Kmietczyk, Ellen Malovrh, Mirko Völkers. N6-Methyladenosine in the Heart. 2021, 309-323.
    59. Matthew R. Burroughs, Juan C. Gonzalez-Rivera, Antonio Cordova, Lydia M. Contreras. Experimental and Computational Methods for Guiding Identification and Characterization of Epitranscriptome Proteins. 2021, 593-632.
    60. Christoph Dieterich, Mirko Völkers. RNA modifications in cardiovascular disease—An experimental and computational perspective. 2021, 113-125.
    61. Liang Hao, Jia-Mei Wang, Bao-Qin Liu, Jing Yan, Chao Li, Jing-Yi Jiang, Fu-Ying Zhao, Huai-Yu Qiao, Hua-Qin Wang. m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2021, 1868 (1) , 118878.
    62. Dibyajyoti Pramanik, Rahul Mahadev Shelake, Mi Jung Kim, Jae-Yean Kim. CRISPR-Mediated Engineering across the Central Dogma in Plant Biology for Basic Research and Crop Improvement. Molecular Plant 2021, 14 (1) , 127-150.
    63. Wenhui Zhang, Qiong Wu. Applications of phage-derived RNA-based technologies in synthetic biology. Synthetic and Systems Biotechnology 2020, 5 (4) , 343-360.
    64. Anil K Chokkalla, Suresh L Mehta, Raghu Vemuganti. Epitranscriptomic regulation by m 6 A RNA methylation in brain development and diseases. Journal of Cerebral Blood Flow & Metabolism 2020, 40 (12) , 2331-2349.
    65. Mengnuo Chen, Chun-Ming Wong. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Molecular Cancer 2020, 19 (1)
    66. Meng Zhang, Yanhui Zhai, Sheng Zhang, Xiangpeng Dai, Ziyi Li. Roles of N6-Methyladenosine (m6A) in Stem Cell Fate Decisions and Early Embryonic Development in Mammals. Frontiers in Cell and Developmental Biology 2020, 8
    67. Jie Zhao, Bing Li, Jianxiong Ma, Weilin Jin, Xinlong Ma. Photoactivatable RNA N 6 ‐Methyladenosine Editing with CRISPR‐Cas13. Small 2020, 16 (30)
    68. Jiexin Li, Zhuojia Chen, Feng Chen, Guoyou Xie, Yuyi Ling, Yanxi Peng, Yu Lin, Nan Luo, Cheng-Ming Chiang, Hongsheng Wang. Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein. Nucleic Acids Research 2020, 48 (10) , 5684-5694.
    69. Jing Gu, Jun Xu, Qidong You, Xiaoke Guo. Recent developments of small molecules targeting RNA m6A modulators. European Journal of Medicinal Chemistry 2020, 196 , 112325.
    70. Xingbo Xu, Melanie S. Hulshoff, Xiaoying Tan, Michael Zeisberg, Elisabeth M. Zeisberg. CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications. International Journal of Molecular Sciences 2020, 21 (9) , 3038.
    71. Michal Burmistrz, Kamil Krakowski, Agata Krawczyk-Balska. RNA-Targeting CRISPR–Cas Systems and Their Applications. International Journal of Molecular Sciences 2020, 21 (3) , 1122.
    72. Jun Liu, Xiaoyang Dou, Chuanyuan Chen, Chuan Chen, Chang Liu, Meng Michelle Xu, Siqi Zhao, Bin Shen, Yawei Gao, Dali Han, Chuan He. N 6 -methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science 2020, 367 (6477) , 580-586.
    73. Juan C. Gonzalez-Rivera, Asuka A. Orr, Sean M. Engels, Joseph M. Jakubowski, Mark W. Sherman, Katherine N. O'Connor, Tomas Matteson, Brendan C. Woodcock, Lydia M. Contreras, Phanourios Tamamis. Computational evolution of an RNA-binding protein towards enhanced oxidized-RNA binding. Computational and Structural Biotechnology Journal 2020, 18 , 137-152.
    74. Brandon J. Davis, Mitchell R. O’Connell. Put on Your Para-spectacles: The Development of Optimized CRISPR-Cas13-Based Approaches to Image RNA Dynamics in Real Time. Molecular Cell 2020, 77 (2) , 207-209.
    75. Yu Pei, Mingxing Lu. Programmable RNA manipulation in living cells. Cellular and Molecular Life Sciences 2019, 76 (24) , 4861-4867.
    76. X. Shawn Liu, Rudolf Jaenisch. Editing the Epigenome to Tackle Brain Disorders. Trends in Neurosciences 2019, 42 (12) , 861-870.
    77. Krysten A Jones, Julia Zinkus-Boltz, Bryan C Dickinson. Recent advances in developing and applying biosensors for synthetic biology. Nano Futures 2019, 3 (4) , 042002.
    78. Kristina Rau, Lukas Rösner, Andrea Rentmeister. Sequence-specific m 6 A demethylation in RNA by FTO fused to RCas9. RNA 2019, 25 (10) , 1311-1323.
    79. Jiangbo Wei, Chuan He. Site-specific m6A editing. Nature Chemical Biology 2019, 15 (9) , 848-849.
    80. Simone Rauch, Emily He, Michael Srienc, Huiqing Zhou, Zijie Zhang, Bryan C. Dickinson. Programmable RNA-Guided RNA Effector Proteins Built from Human Parts. Cell 2019, 178 (1) , 122-134.e12.
    81. Hailing Shi, Jiangbo Wei, Chuan He. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Molecular Cell 2019, 74 (4) , 640-650.
    82. Ruiqing Yu, Qimeng Li, Zhihui Feng, Luhui Cai, Qiong Xu. m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response. International Journal of Molecular Sciences 2019, 20 (6) , 1323.
    83. Simone Rauch, Bryan C. Dickinson. Targeted m6A reader proteins to study the epitranscriptome. 2019, 1-16.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect